MARKET

XTLB

XTLB

X T L Bio
NASDAQ

Real-time Quotes | Nasdaq Last Sale

4.293
+0.183
+4.46%
Closed 16:00 09/24 EDT
OPEN
4.140
PREV CLOSE
4.110
HIGH
4.410
LOW
4.039
VOLUME
29.33K
TURNOVER
--
52 WEEK HIGH
6.69
52 WEEK LOW
1.731
MARKET CAP
22.67M
P/E (TTM)
-28.6207
1D
5D
1M
3M
1Y
5Y
Dr. Morris C. Laster Files Preliminary Proxy Statement Nominating Two Highly-Qualified Individuals For Election To Board At Scopus BioPharma Inc.'s 2021 Annual Meeting
/PRNewswire/ -- Dr. today announced that he has filed preliminary proxy materials with the Securities and Exchange Commission ("SEC") in connection with the 2021 Annual Meeting of Stockholders ("Annual Meeting") of Scopus BioPharma Inc. (Nasdaq: SCPS) ("S...
PR Newswire - PRF · 4d ago
Triple-S Management, Bio-Path leads healthcare gainers; Theravance Biopharma, Vivos Therapeutics among major losers
Gainers: Triple-S Management (NYSE:GTS) +45%, Bio-Path (NASDAQ:BPTH) +21%, Reviva Pharmaceuticals (NASDAQ:RVPH) +21%, XTL Biopharmaceuticals (NASDAQ:XTLB) +13%, Protara Therapeutics (NASDAQ:TARA) +12%. Losers: Theravance Biopharma (NASDAQ:TBPH) -31%, Vivos...
Seekingalpha · 08/24 15:10
60 Biggest Movers From Yesterday
Gainers Trillium Therapeutics Inc. (NASDAQ: TRIL) shares jumped 188.8% to close at $17.59 on Monday after the company agreed to be acquired by Pfizer for $18.50 per share, implying an equity value of $2.26 billion.
Benzinga · 08/24 09:11
12 Health Care Stocks Moving In Monday's Pre-Market Session
 
Benzinga · 08/23 12:12
25 Stocks Moving in Monday's Pre-Market Session
Gainers
Benzinga · 08/23 11:00
58 Biggest Movers From Friday
Gainers Regencell Bioscience Holdings Limited (NASDAQ: RGC) shares climbed 204.1% to close at $19.16 on Friday. Regencell Bioscience reported partial exercise of underwriter’s over-allotment option.
Benzinga · 08/23 09:06
ONVO, JOBY and PXLW among mid-day movers
Gainers: Greenpro Capital (NASDAQ:GRNQ) +61%. GeoVax Labs (NASDAQ:GOVX) +49%. Flora Growth Corp. (NASDAQ:FLGC) +31%. Pixelworks (NASDAQ:PXLW) +20%. XTL Biopharmaceuticals (NASDAQ:XTLB) +18%. Leju Holdings (NYSE:LEJU) +17%. Zhihu (NYSE:ZH) +17%. Organovo (N...
Seekingalpha · 08/20 16:34
GeoVax Labs, Flora Growth leads healthcare gainers; Progenity, Sonnet BioTherapeutics among major losers
Gainers: GeoVax Labs (NASDAQ:GOVX) +52%, Flora Growth (NASDAQ:FLGC) +30%, XTL Biopharmaceuticals (NASDAQ:XTLB) +17%, Organovo (NASDAQ:ONVO) +16%, Impel NeuroPharma (NASDAQ:IMPL) +11%. Losers: Progenity (NASDAQ:PROG) -55%, Sonnet BioTherapeutics (NASDAQ:SON...
Seekingalpha · 08/20 15:04
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of XTLB. Analyze the recent business situations of X T L Bio through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
EPS
Institutional Holdings
Institutions: 6
Institutional Holdings: 526.66K
% Owned: 9.97%
Shares Outstanding: 5.28M
TypeInstitutionsShares
Increased
1
38
New
0
0
Decreased
2
4.32K
Sold Out
1
3.52K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Biotechnology & Medical Research
-2.13%
Pharmaceuticals & Medical Research
-1.02%
Key Executives
Chairman/Director
Shlomo Shalev
Chief Executive Officer
Joshua Levine
Deputy Chief Executive Officer/Chief Financial Officer
Ronen Twito
Other
Moshe Mittelman
Director
Daphna Paran
Director
Alexander Rabinovitch
Non-Executive Director
Dafna Cohen
Non-Executive Director
Jaron Diament
No Data
About XTLB
XTL Biopharmaceuticals Ltd. is a biopharmaceutical company engaged in the acquisition and development of pharmaceutical drugs for the treatment of autoimmune diseases. The Company pipelines include hCDR1 systematic lupus erythematosus and recombinant human erythropoietin (rHuEPO) multiple myeloma. Its hCDR1, which is a potential treatment for systemic lupus erythematosus (SLE) and Sjogren’s syndrome (SS). hCDR1 is a peptide (short protein) that is administered subcutaneously and acts as a disease-specific treatment to modify the SLE-related autoimmune process. The rHuEPO known agent for anemia to prolong the survival of patients for the treatment of multiple myeloma blood cancer. Its Erythropoietin (EPO) is a glycoprotein hormone produced mainly by the kidney. EPO stimulates erythropoiesis, the production of red blood cells, by binding to its receptor on the surface of erythroid progenitor cells, promoting their proliferation and differentiation and maintaining their viability.

Webull offers kinds of X T L Biopharmaceuticals Ltd (ADR) stock information, including NASDAQ:XTLB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, XTLB stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading XTLB stock methods without spending real money on the virtual paper trading platform.